FLT4 and squamous cell carcinoma: Later studies discovered that VEGF-C’s primary receptor Flt4/VEGFR-3 is expressed in a variety of human malignancies, including lung, colorectal, prostate, and squamous cell carcinomas of the head and neck as well as Kaposi’s sarcoma [28].